JOANN FERLAND: Open Payments
NPI 1124024344 · PLEASANT VIEW, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 39 payments from 16 companies in 2025. Trend: 2023 $440 · 2024 $966 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $186 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| PFIZER INC. | 4 | $74 |
| Corcept Therapeutics | 2 | $55 |
| Lilly USA, LLC | 3 | $52 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $43 |
| Amgen Inc. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
Products named: FARXIGA, REXULTI, NURTEC ODT, Korlym, GEMTESA, QULIPTA, Veozah, OTEZLA.
Industry payments across TN — which companies pay providers there.
